General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 361: All of the following statements are true regarding hyperplasia, except:

A. Seen in cells capable of dividing (labile cells)
B. There is an increase in the number of cells
C. Pathological hyperplasia can be a risk factor for malignancy
D. Bone marrow hyperplasia is not seen in response to peripheral blood cytopenias (Correct Answer)

Explanation: ### Explanation **Hyperplasia** is defined as an increase in the number of cells in an organ or tissue, usually resulting in increased mass [1]. It occurs when the cell population is capable of replication. **1. Why Option D is the Correct Answer (The False Statement):** Bone marrow hyperplasia is a classic **compensatory physiological response** to peripheral blood cytopenias. For example, in chronic hemolytic anemia, the bone marrow undergoes erythroid hyperplasia to increase the production of red blood cells [2]. Therefore, the statement that it is "not seen" is incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** Hyperplasia occurs in cells capable of DNA synthesis and mitotic division, such as **labile cells** (e.g., epidermis, intestinal epithelium) and **stable cells** (e.g., hepatocytes) [2]. It does not occur in permanent cells (e.g., cardiac muscle, neurons), which undergo hypertrophy instead. * **Option B:** This is the fundamental definition of hyperplasia—an increase in cell number due to proliferation [1]. * **Option C:** While hyperplasia is a controlled process, **pathological hyperplasia** (e.g., endometrial hyperplasia due to excess estrogen) provides a fertile soil in which cancerous proliferation may eventually arise. **3. High-Yield Clinical Pearls for NEET-PG:** * **Hypertrophy vs. Hyperplasia:** Hypertrophy is an increase in cell *size*; Hyperplasia is an increase in cell *number* [1]. They often occur together (e.g., pregnant uterus). * **Mechanism:** Driven by growth factor-stimulated proliferation of mature cells or increased output of new cells from tissue stem cells [2]. * **Key Examples:** * *Hormonal:* Breast development at puberty [1]. * *Compensatory:* Liver regeneration after partial hepatectomy [2]. * *Pathological:* Benign Prostatic Hyperplasia (BPH), HPV-induced skin warts [1]. * **Important Exception:** Benign Prostatic Hyperplasia (BPH) is **not** a risk factor for prostate cancer, unlike endometrial hyperplasia which is a risk factor for endometrial carcinoma. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 85-88. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-113.

Question 362: Hypoxia is a common cause of cell injury. Which of the following is NOT a cause of hypoxia?

A. Ischemia
B. Respiratory failure
C. Carbon monoxide poisoning
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Hypoxia** is defined as a deficiency of oxygen reaching the tissues, which is a critical cause of cell injury [2]. It is important to distinguish it from **Ischemia**, which is a loss of blood supply (and thus oxygen + nutrients) to a tissue. **Why "All of the above" is correct:** All three options represent different mechanisms that lead to a reduction in oxygen delivery to the cells: 1. **Ischemia (Option A):** This is the most common cause of hypoxia [2]. It occurs due to reduced arterial flow or reduced venous drainage. Unlike pure hypoxia, ischemia also results in a lack of nutrients (like glucose) and the accumulation of metabolic wastes. 2. **Respiratory Failure (Option B):** This leads to **Hypoxemic Hypoxia**. If the lungs cannot oxygenate the blood (due to pneumonia, COPD, or high altitude), the partial pressure of oxygen ($PaO_2$) in the arterial blood drops, leading to tissue hypoxia [3]. 3. **Carbon Monoxide (CO) Poisoning (Option C):** This leads to **Anemic Hypoxia**. CO has a much higher affinity for hemoglobin than oxygen [1]. It forms carboxyhemoglobin, which prevents oxygen binding and shifts the oxygen-dissociation curve to the left, reducing oxygen delivery to tissues. **NEET-PG High-Yield Clinical Pearls:** * **Ischemia vs. Hypoxia:** Ischemia injures tissues faster than hypoxia because it deprives cells of glycolytic substrates and prevents the removal of toxic metabolites [2]. * **Cyanide Poisoning:** This causes **Histotoxic Hypoxia**, where oxygen is present in the blood, but cells cannot utilize it because cyanide inhibits **Cytochrome Oxidase** in the mitochondria. * **First Sign of Hypoxic Injury:** The earliest change is the failure of the **Na+/K+ ATPase pump** due to ATP depletion, leading to **acute cellular swelling** (hydropic change). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 99-100. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 55-56. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 140-142.

Question 363: Which interleukin is characteristically produced by TH1 cells?

A. Interleukin 2 (Correct Answer)
B. Interleukin 5
C. Interleukin 4
D. Interferon gamma

Explanation: The differentiation of CD4+ T-helper cells into subsets (TH1 and TH2) is a fundamental concept in immunology. **TH1 cells** are primarily involved in cell-mediated immunity and the activation of macrophages [1]. They characteristically produce **Interleukin-2 (IL-2)** and **Interferon-gamma (IFN-γ)** [1]. While both IL-2 and IFN-γ are TH1 cytokines, **IL-2** is the classic T-cell growth factor that promotes the proliferation of T-lymphocytes (autocrine and paracrine action). In the context of standard pathology textbooks (like Robbins), IL-2 and IFN-γ are the hallmark secretions of the TH1 subset. **Analysis of Options:** * **Option A (IL-2):** Correct. It is a signature TH1 cytokine responsible for T-cell proliferation [1]. * **Option B & C (IL-4 & IL-5):** Incorrect. These are characteristic **TH2 cytokines** [3]. IL-4 induces IgE class switching, and IL-5 activates eosinophils [3]. (Mnemonic: TH2 secretes IL-4, 5, 6, 10, and 13). * **Option D (IFN-γ):** While also produced by TH1 cells, in many standardized MCQ formats, if both are present, IL-2 is often highlighted as the primary growth factor, though IFN-γ is the primary macrophage activator [1]. *Note: In some clinical contexts, IFN-γ is considered the "most" characteristic, but IL-2 remains a definitive TH1 product.* **High-Yield Clinical Pearls for NEET-PG:** * **TH1 Differentiation:** Induced by **IL-12** and **IFN-γ**. It activates the **STAT4** and **T-bet** transcription factors. * **TH2 Differentiation:** Induced by **IL-4**. It activates **STAT6** and **GATA-3**. * **TH17:** Produces **IL-17**; involved in neutrophil recruitment and fungal infections [2]. * **Clinical Link:** Lepromatous leprosy shows a TH2 response (poor prognosis), while Tuberculoid leprosy shows a TH1 response (better containment). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 216-218. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 218. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 210.

Question 364: Granularity of oncocyte cytoplasm is due to which cellular organelle?

A. Overabundance of Golgi bodies
B. Overabundance of mitochondria (Correct Answer)
C. Deficiency of mitochondria
D. Deficiency of Golgi bodies

Explanation: ### Explanation **Correct Answer: B. Overabundance of mitochondria** **Mechanism:** Oncocytes (also known as Hürthle cells in the thyroid) are large epithelial cells characterized by an abundant, intensely eosinophilic, and **granular cytoplasm**. This distinct appearance is due to the **compensatory overabundance of mitochondria** [1]. These mitochondria are often structurally abnormal and dysfunctional; to compensate for their poor efficiency in ATP production, the cell undergoes massive mitochondrial biogenesis, filling the cytoplasm with these organelles. On light microscopy, these packed mitochondria appear as fine acidophilic granules [1]. **Analysis of Incorrect Options:** * **A & D (Golgi bodies):** While Golgi bodies are essential for protein packaging, they do not contribute to the characteristic granular eosinophilia of oncocytes. An overabundance of Golgi usually results in a "perinuclear halo" or clear zone rather than diffuse granularity. * **C (Deficiency of mitochondria):** This is the opposite of the actual pathology. A deficiency of mitochondria would lead to a pale or vacuolated cytoplasm, not the dense granularity seen in oncocytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Common Locations:** Oncocytes are most frequently encountered in the **Salivary glands** (Warthin’s tumor and Oncocytoma), **Thyroid gland** (Hürthle cell adenoma/carcinoma), and **Kidney** (Renal oncocytoma). * **Staining:** On electron microscopy, the cytoplasm is seen packed with mitochondria. On immunohistochemistry, they stain positive for mitochondrial antigens. * **Hürthle Cells:** In the context of **Hashimoto’s Thyroiditis**, these cells are a hallmark finding, representing metaplastic changes of follicular epithelial cells in response to chronic inflammation. * **Renal Oncocytoma:** Characteristically presents with a "central stellate scar" on gross morphology. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1103-1104.

Question 365: All of the following are true regarding innate immunity except:

A. NADPH oxidase generates superoxide ions.
B. Chediak-Higashi syndrome is due to defective phagolysosome formation.
C. In Bruton's agammaglobulinemia, opsonization is impaired. (Correct Answer)
D. Myeloperoxidase action is mainly due to hypochlorous acid (HOCl).

Explanation: This question tests the distinction between **Innate** and **Adaptive** immunity. ### **Explanation of the Correct Answer (Option C)** The question asks for the statement that is **NOT** true regarding **Innate Immunity**. **Bruton’s Agammaglobulinemia** (X-linked agammaglobulinemia) is a primary immunodeficiency characterized by a failure of B-cell maturation due to a mutation in the *BTK* gene [1]. Since B-cells are the mediators of **Humoral (Adaptive) Immunity**, any defect in antibody production—and the subsequent impairment of opsonization—is a failure of the **Adaptive immune system**, not the Innate system. Therefore, while the statement itself is clinically true, it does not pertain to innate immunity. ### **Analysis of Other Options (Innate Immunity Mechanisms)** * **Option A:** True. During the "Respiratory Burst," **NADPH oxidase** (located in the phagosome membrane) reduces oxygen to **Superoxide radicals** ($O_2^-$), the first step in killing ingested microbes. * **Option B:** True. **Chediak-Higashi syndrome** is an autosomal recessive disorder involving a defect in the *LYST* gene (lysosomal trafficking regulator), leading to impaired **phagolysosome formation** [2]. * **Option D:** True. **Myeloperoxidase (MPO)**, found in neutrophil azurophilic granules, converts hydrogen peroxide ($H_2O_2$) and chloride ions into **Hypochlorous acid (HOCl)**, which is the most potent bactericidal system of neutrophils. ### **High-Yield Clinical Pearls for NEET-PG** * **Chronic Granulomatous Disease (CGD):** Caused by a deficiency in **NADPH oxidase**. Diagnosis is made via the **Nitroblue Tetrazolium (NBT) test** (negative/colorless) or Dihydrorhodamine (DHR) flow cytometry. * **Chediak-Higashi Hallmark:** Look for **giant lysosomal granules** in neutrophils and platelets on a peripheral smear [2]. * **MPO Deficiency:** Most patients are asymptomatic, but they have an increased risk of disseminated *Candida* infections. * **Opsonins:** The most important opsonins in the body are **IgG** and **C3b**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 248-249. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 245-246.

Question 366: Which of the following pigments are involved in free radical injury?

A. Lipofuscin (Correct Answer)
B. Melanin
C. Bilirubin
D. Hematin

Explanation: **Explanation:** **Lipofuscin** (Option A) is the correct answer because it is the hallmark pigment of **lipid peroxidation**, a key mechanism of free radical injury [1]. It is an insoluble, brownish-yellow granular pigment composed of polymers of lipids and phospholipids complexed with protein [1]. It accumulates in cells (especially permanent cells like neurons and cardiac myocytes) as a result of the free radical-catalyzed breakdown of polyunsaturated lipids in subcellular membranes [1], [2]. Because it increases with age, it is also known as the **"wear-and-tear"** or **"aging"** pigment. **Why other options are incorrect:** * **Melanin (Option B):** An endogenous black-brown pigment produced by melanocytes in the basal layer of the epidermis [1]. Its primary function is protection against UV radiation, not a byproduct of free radical damage. * **Bilirubin (Option C):** A yellow-green pigment derived from the catabolism of heme [3]. It is a normal metabolic byproduct and its accumulation (jaundice) indicates hepatobiliary or hemolytic disorders [3]. * **Hematin (Option D):** A derivative of hemoglobin formed by the oxidation of the iron atom from the ferrous ($Fe^{2+}$) to the ferric ($Fe^{3+}$) state. It is often seen as an artifact or in certain parasitic infections (e.g., Malaria pigment/Hemozoin). **High-Yield Clinical Pearls for NEET-PG:** * **Brown Atrophy:** Extensive accumulation of lipofuscin in an organ (like the heart) leads to a reduction in size and a brownish discoloration, termed "brown atrophy." * **Location:** Lipofuscin is typically found in a **perinuclear** distribution [1]. * **Significance:** It is not toxic to the cell itself but serves as a "tell-tale" sign of past free radical/oxidative stress [1]. * **Staining:** It is positive with **Sudan Black B** and **PAS** stains. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 59. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 639-640.

Question 367: Which of the following is NOT true about apoptosis?

A. Inflammation is present (Correct Answer)
B. Chromosomal breakage
C. Clumping of chromatin
D. Cell shrinkage

Explanation: Apoptosis is a form of **programmed cell death** characterized by a series of tightly regulated events that eliminate cells without eliciting an immune response [3]. **1. Why "Inflammation is present" is the correct (NOT true) statement:** Unlike necrosis, where the cell membrane ruptures and releases intracellular contents into the surrounding tissue (triggering an inflammatory response), apoptosis maintains **membrane integrity**. The dead cell is rapidly broken into **apoptotic bodies**, which display "eat-me" signals (like phosphatidylserine) on their surface [4]. These are immediately engulfed by macrophages before any leakage occurs [4]. Therefore, **inflammation is characteristically absent** in apoptosis [4]. **2. Analysis of incorrect options (Features that ARE true of apoptosis):** * **Cell Shrinkage:** This is a hallmark of apoptosis. The cell becomes smaller, the cytoplasm is dense, and organelles are tightly packed. * **Clumping of Chromatin:** This is the most characteristic feature of apoptosis. Chromatin aggregates peripherally under the nuclear membrane (pyknosis). * **Chromosomal Breakage:** DNA is cleaved by Ca²⁺ and Mg²⁺-dependent endonucleases into fragments of 180–200 base pairs, appearing as a **"Step-ladder pattern"** on gel electrophoresis. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Detection:** TUNEL assay (detects DNA fragmentation). * **Morphological Hallmark:** Formation of apoptotic bodies [4]. * **Key Enzyme:** Caspases (Cysteine aspartic acid-specific proteases) [2]. * **Anti-apoptotic genes:** Bcl-2, Bcl-xL [1]. * **Pro-apoptotic genes:** Bax, Bak [1]. * **Mitochondrial Pathway:** Involves the release of **Cytochrome c** into the cytosol [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 310. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69.

Question 368: What is the most common cause of Down syndrome?

A. Maternal nondisjunction (Correct Answer)
B. Paternal nondisjunction
C. Translocation
D. Mosaicism

Explanation: **Explanation:** Down syndrome (Trisomy 21) is the most common chromosomal disorder [1], [4]. The correct answer is **Maternal nondisjunction** because it accounts for approximately **95%** of all cases. 1. **Why Maternal Nondisjunction is Correct:** Nondisjunction refers to the failure of sister chromatids or homologous chromosomes to separate during meiosis. In Down syndrome, this typically occurs during **Meiosis I** in the maternal ovum. The risk increases exponentially with **advanced maternal age** (especially >35 years) [1], [4] because ova are suspended in Prophase I (Dictyotene stage) from birth until ovulation, making them susceptible to cumulative environmental damage and spindle failure. 2. **Why Other Options are Incorrect:** * **Paternal Nondisjunction:** While it can occur, it accounts for only about 3–5% of cases. * **Translocation:** This accounts for ~4% of cases. It usually involves a **Robertsonian translocation**, most commonly between chromosomes 14 and 21 [t(14;21)] [3]. Unlike nondisjunction, this is independent of maternal age and can be inherited from a carrier parent [3]. * **Mosaicism:** This is the rarest form (~1–2%), occurring due to **mitotic nondisjunction** during early embryonic development [3]. These patients often have a milder phenotype because only a fraction of their cells carry the extra chromosome [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Maternal nondisjunction (95%). * **Most common translocation:** t(14;21) [2]. * **Screening:** First-trimester screening shows **increased nuchal translucency**, **decreased PAPP-A**, and **increased β-hCG**. * **Quadruple Test (Second Trimester):** Low AFP, Low Estriol, High hCG, and High Inhibin-A (Mnemonic: **HI**gh = **H**CG & **I**nhibin). * **Associated Risks:** Early-onset Alzheimer’s (APP gene on Ch 21), Acute Leukemia (ALL >5 years; AMKL <5 years), and Endocardial Cushion Defects (ASD/VSD). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 40-41. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 171-172. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 170-171. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93.

Question 369: Which of the following is NOT a feature of malignant transformation by cultured cells?

A. Increased cell density
B. Increased requirement for growth factors (Correct Answer)
C. Alterations of cytoskeletal structures
D. Loss of anchorage

Explanation: **Explanation:** Malignant transformation refers to the phenotypic changes that occur when normal cells transition into cancer cells. A hallmark of cancer is **self-sufficiency in growth signals** [1]. **Why B is the correct answer:** Normal cells require exogenous growth factors to transition from the G0/G1 phase into the S phase. In contrast, malignant cells exhibit a **decreased requirement for growth factors**. They achieve this through autocrine stimulation (secreting their own growth factors), overexpressing receptors, or activating downstream signaling pathways (like the RAS/MAPK pathway) that bypass the need for external triggers [1]. Therefore, an *increased* requirement is incorrect. **Analysis of Incorrect Options:** * **A. Increased cell density:** Normal cells exhibit "contact inhibition," stopping growth when they touch neighbors. Malignant cells lose this inhibition, piling up to form high-density multilayered foci. * **C. Alterations of cytoskeletal structures:** Transformed cells often show a disorganized cytoskeleton (e.g., changes in actin microfilaments), which contributes to their characteristic rounded shape and increased motility. * **D. Loss of anchorage:** Normal cells are "anchorage-dependent" and require attachment to a solid substrate (extracellular matrix) to survive. Malignant cells can grow in suspension or semi-solid media (like agar), a property known as anchorage-independent growth. **NEET-PG High-Yield Pearls:** * **Warburg Effect:** Transformed cells prefer aerobic glycolysis over oxidative phosphorylation, even in the presence of oxygen [1]. * **Telomerase Activation:** Malignant cells avoid senescence by upregulating telomerase, leading to "immortality." * **E-Cadherin Loss:** The loss of E-cadherin is a key step in the Epithelial-Mesenchymal Transition (EMT), facilitating metastasis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 290-291.

Question 370: In Lysosomal storage disorders, which of the following statements is true?

A. Lysosomes are deficient in the enzyme hydrolase. (Correct Answer)
B. There is a defect in the fusion of lysosomes and phagosomes.
C. There is a defect in the lysosomal membrane.
D. There is increased degradation of heteroglycans.

Explanation: **Explanation:** **1. Why Option A is Correct:** Lysosomal Storage Disorders (LSDs) are a group of approximately 50 genetic metabolic diseases. The fundamental pathogenesis is the **inherited deficiency of specific lysosomal acid hydrolases** [1]. Lysosomes are the primary digestive units of the cell; when a specific hydrolase is missing or inactive, the substrate intended for degradation cannot be broken down. This leads to the progressive **intracellular accumulation (storage)** of partially degraded insoluble metabolites within the lysosomes, eventually causing cellular dysfunction and organomegaly [1]. **2. Why Incorrect Options are Wrong:** * **Option B:** A defect in the fusion of lysosomes and phagosomes is the hallmark of **Chediak-Higashi Syndrome**, not LSDs. While it involves lysosomes, the primary issue is microtubule polymerization and vesicle trafficking, not enzyme deficiency. * **Option C:** While rare defects in lysosomal membrane proteins exist (e.g., Cystinosis), the vast majority of LSDs are defined by **luminal enzyme deficiencies**, making Option A the most characteristic general statement [1]. * **Option D:** In LSDs, there is **decreased** (not increased) degradation of macromolecules like glycosaminoglycans (mucopolysaccharides), sphingolipids, and glycogen [1]. **3. NEET-PG High-Yield Pearls:** * **Inheritance:** Most LSDs are **Autosomal Recessive**, except for **Fabry disease** and **Hunter syndrome**, which are **X-linked Recessive**. * **Most Common LSD:** Gaucher Disease (Deficiency of Glucocerebrosidase) [1]. * **I-Cell Disease:** A unique LSD where enzymes are synthesized but fail to reach the lysosome due to a deficiency in **Mannose-6-Phosphate (M6P)** tagging [1]. * **Clinical Triad:** Often presents with hepatosplenomegaly, skeletal abnormalities, and neurodegeneration (in many types) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 159-161.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free